| D1 S1 0 Inaugural Session - Sai-Prasad |
|
| D1 S1 1 Inaugural Session - Dr. Tedros WHO |
|
| D1 S1 6 Inaugural Session - Dr. Carissa Etienne, PAHO |
|
| D1 S1 7 Inaugural Session - Nikolaj Gilbert, PATH |
|
| D1 S2 1 Pandemic Preparedness Response - Kerim Chitour, PATH |
|
| D1 S2 2 Pandemic Preparednes Response - Thomas_Cueni, IFPMA |
|
| D1 S2 4 Pandemic Preparedness Response -Adam Hacker, CEPI |
|
| D1 S2 6 Pandemic Preparedness Response - Farid Fezoua, IFC |
|
| D1 S2 7 Pandemic Preparedness Response - Marie Mazur, Ready2respond |
|
| D2 S1 01 Africa Forum- Kick the Tyres -Nicaise Ndembi, Africa CDC |
|
| D2 S1 02 Simone Blayer 2022 10 21-PATH-DCVMN-AGM-Presentation-For Distribution |
|
| D2 S2 Sustainability and Lessons Learnt - WHO mRNA Tech Transfer Sustainability Presentation_2022 |
|
| D2 S4 1 Regulatory & PQ- Rogerio Gaspar, WHO |
|
| D2 S4 8 Pieter Neels vaccine Platform technology_EN |
|
| D2 S5 0 Innovation in Finance & Technology -Chair James Polan US IDFCv |
|
| D2 S5 1 Innovation in Finance & Technology - Raman Rao, Hilleman |
|
| D2 S5 2 Innovation in Finance & Technology, Brandon Ball, Zebra |
|
| D2 S5 3 Innovation in Finance & Technology -Andrew Wong, Walvax |
|
| D2 S5 4 Innovation in Finance & Technology -Kutub Mahmood, PATH |
|
| D2 S5 5 Innovation in Finance & Technology - Andreas Castan, Cytiva |
|
| D2 S5 6 Innovation in Finance & Technology -Calman MacLennan, BMGF |
|
| D2 S5 7 Innovation in Finance & Technology - Vikrant Hedau- Tofflon |
|
| D3 S1 0 Roadmap to Future Vaccines - Framing- Birgitte Giersing |
|
| D3 S1 1 Roadmap to Future Vaccines- Gagandeep Kang, CMCV |
|
| D3 S1 2 Roadmap to Future Vaccines -Sai Prasad, Bharat Biotech |
|
| D3 S1 3 Roadmap to Future Vaccines - Prashant Yadav, CGD |
|
| D3 S1 4 Roadmap to Future Vaccines- Chunlin Xin, CanSino |
|
| D3 S1 5 Roadmap to Future Vaccines -Kamel Senouci ADVAC |
|
| D3 S2 Capacity Building Panel_Consolidated Slides |
|
| D3 S3 1 Key Learnings from Working Groups - Rachel Park, DCVMN Supply Chain |
|
| D3 S3 2 Key Learnings from Working Groups - Sebastian Comellas, DCVMN Regulartory Affairs WG |
|
| D3 S3 3 Key Learnings from Working Groups, Viska Indriani, DCVMN Pharmacovigilance Affairs WG |
|
| D3 S3 4 Key Learnings from Working Groups - Adriansjah Azhari, DCVMN Covid Committee |
|
| D3 S4 01 Innovative Technologies - Subhasis Banerjee, Merck |
|
| D3 S4 02 Innovative Technologies - Raman Rani, Sartorius |
|
| D3 S4 03 Innovative Technologies - Shaobin Mike Lu, Bioengineering |
|
| D3 S4 04 Innovative Technologies - Devak Padmanabhan, BiOZEEN |
|
| D3 S4 05 Innovative Technologies - Pratik Gajjar, Univercells Technologies |
|
| D3 S4 06 Innovative Technologies - Surajit Chandra, Telstar |
|
| D3 S4 07 Innovative Technologies - Seshu Tirumala, Stevanato |
|
| D3 S4 08 Innovative Technologies - Ozge Goktekin, Pharmajet |
|
| D3 S4 09 Innovative Technologies - Rajkumar Gaikwad, TRUKING |
|
| D3 S4 10 Innovative Technologies - Tulip Nuwal, OmniBRx |
|
